Results from in silico analysis using MaaT Pharma’s data analysis platform, GutPrint, demonstrate therapeutic rationale…
MaaT PharmaSeptember 18, 2018
Dr. Joël Doré, MaaT Pharma’s co-founder, received awards for his work Created in the…
MaaT PharmaMay 18, 2018
MaaT Pharma, a clinical-stage biopharmaceutical company, received authorization from competent authorities to launch its phase…
MaaT PharmaMarch 5, 2018
The French Microbiome company completed its first clinical study proving that Autologous Fecal Microbiota Transfer…
MaaT PharmaNovember 30, 2017
Maat Pharma has reached the target number of patients to be treated in its first…
MaaT PharmaJuly 20, 2017
Lyon (France), June 15, 2017. A few days after signing a strategic partnership for the…
MaaT PharmaJune 15, 2017
MaaT Pharma and BIOASTER just entered into an agreement to investigate the potentiality to expand…
MaaT PharmaFebruary 16, 2017
